Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-1,004,0867 Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutations
It has been established that cancer cells with oncogenic mutants in the small GTPase K-Ras are susceptible to antibodies that bind intracellular guanosine, but...
US-1,004,0866 Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses...
The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof,...
US-1,004,0865 T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2
The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human...
US-1,004,0864 Anti-OX40 antibodies and their uses
The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making...
US-1,004,0863 Anticancer agent
According to the present invention, an anticancer agent is provided that has as an active ingredient thereof a human antibody light chain that demonstrates...
US-1,004,0862 Humanized and chimeric monoclonal antibodies to CD99
Humanized or chimeric anti-CD99 monoclonal antibodies are provided. The antibodies bind to and neutralize human CD99, and find use in various therapeutic...
US-1,004,0861 Antibody variants composition
Among N-glycoside-linked sugar chains which are bound to the Fc region of an antibody, sugar chains which are bound to Asn at position 297 relates to the...
US-1,004,0860 Therapeutic antibodies and their uses
The present invention relates to antibodies, e.g., full length antibodies or antigen binding fragments thereof, that specifically bind to BCMA (B-Cell...
US-1,004,0859 Methods of treating hemophagocytic lymphohistiocytosis with an IL-33 receptor antibody
Compositions and methods for treating a cytokine release syndrome such as chimeric antigen receptor T-cell cytokine release syndrome or hemophagocytic...
US-1,004,0858 Anti-CSF1R antibodies for treating PVNS
Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
US-1,004,0857 Binding molecules specific for HER3 and uses thereof
The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various...
US-1,004,0856 Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness...
Provided herein are novel compositions comprising anti-DEspR antibodies and fragments thereof, including fully human, composite engineered human, humanized,...
US-1,004,0855 Formulation for anti-.alpha.4.beta.7 antibody
Antibody formulations are described comprising a mixture of an anti-.alpha.4.beta.7 antibody, an antioxidant or chelator, and at least one free amino acid. The...
US-1,004,0854 Antibodies against CD106 (VCAM-1)
The invention provides an antibody or fragment thereof that specifically binds to human endothelial vascular cell adhesion molecule-1 (VCAM-1), wherein the...
US-1,004,0853 Methods and compositions involving NKG2D inhibitors and cancer
Embodiments methods and compositions involving inhibitors of the immunoreceptor Natural Killer Group 2, Member D, (NKG2D) for inhibiting tumor progression and...
US-1,004,0852 Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have...
US-1,004,0851 Antagonists to IL-6 to raise albumin and/or lower CRP
The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to...
US-1,004,0850 Protecting group comprising a purification tag
The present invention relates to compounds comprising a protecting group moiety-tag moiety conjugate, a method of purification and monoconjugates obtained from...
US-1,004,0849 Caninized anti-nerve growth factor antibodies
A method of preparing an antibody suitable for use in a canine is provided. Also provided are caninized antibodies which specifically bind to canine neuronal...
US-1,004,0848 Chimeric and humanized anti-histone antibodies
The present invention concerns chimeric or humanized antibodies or antigen-binding fragments thereof that comprise specific CDR sequences, disclosed herein....
US-1,004,0847 Methods of treating a tauopathy
The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau...
US-1,004,0846 Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
The present invention provides compositions and methods for generating a genetically modified T cells comprising a chimeric antigen receptor (CAR) having an...
US-1,004,0845 Human cytomegalovirus neutralizing antibodies and use thereof
The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and antibody...
US-1,004,0844 Proteolytic release of cell surface antigens for phage biopanning
The invention described herein features methods of isolating monoclonal antibodies or polypeptides that bind to a cell surface expressed antigen. The method of...
US-1,004,0843 Interleukin-10 fusion proteins and uses thereof
The present invention generally relates to fusion proteins of antibodies and interleukin-10 (IL-10). In addition, the present invention relates to ...
US-1,004,0842 Fibronectin type III domain based scaffold compositions, methods and uses
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin),...
US-1,004,0841 Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof
A stable fusion protein, wherein in solution, a majority of the fusion proteins are in the homo-hexamer form, which may be prepared for example as a CTLA4-FasL...
US-1,004,0840 Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using...
US-1,004,0839 Insulin derivatives and the medical uses hereof
The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically the invention relates to novel...
US-1,004,0838 CRHR2 peptide agonists and uses thereof
The present invention relates to novel peptides that are selective corticotrophin releasing hormone receptor type 2 (CRHR2) agonists and compositions thereof...
US-1,004,0837 Nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression
A nucleic acid or transgene comprising a modified VEGF 3'-untranslated region (3'-UTR) polynucleotide sequence and a polynucleotide sequence encoding a Vascular...
US-1,004,0836 Peptides for the treatment of neurodegenerative diseases
An isolated peptide comprising a Huntingtin (Htt) amino acid sequence being no longer than 15 amino acids, wherein said Htt amino acid sequence comprises the...
US-1,004,0835 Vectors encoding rod-derived cone viability factor
The present invention relates to nucleic acids coding for and capable of expressing a rod-derived cone viability factor (RdCVF) and viral vectors containing...
US-1,004,0834 Biopolymer optofluidic device and method of manufacturing the same
A method of manufacturing a biopolymer optofluidic device including providing a biopolymer, processing the biopolymer to yield a biopolymer matrix solution,...
US-1,004,0833 Nisin production process
The present invention relates to fermentation processes. The objective of the invention was to provide methods for producing nisin containing ferments and...
US-1,004,0832 UspA2 protein constructs and uses thereof
The present invention relates to compositions comprising Moraxella catarrhalis (M. catarrhalis) Ubiquitous surface protein A2 (UspA2). More particularly, the...
US-1,004,0831 Compositions and methods for treating diseases by inhibiting exosome release
A multipartite peptide that inhibits release of exosomes in a cell, comprising an N-terminal end and a C-terminal end and comprising at least one secretion...
US-1,004,0830 Methods and compositions for protein delivery
The present invention provides methods and compositions for protein delivery. The invention features virus like particles, methods of making virus like...
US-1,004,0829 Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the...
A peptide domain necessary for an interaction between an envelope of a virus belonging to an HERV-W interference group and an hASCT receptor comprises (i) an...
US-1,004,0828 Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and...
Nucleic acid molecules and compositions comprising one or more nucleic acid sequences that encode an RSV immunogen are disclosed. Nucleic acid are disclosed...
US-1,004,0827 B-cell receptor complex binding proteins containing T-cell epitopes
The present invention relates to a polypeptide comprising a) a binding peptide binding to at least one protein selected from the group consisting of CD22, CD19,...
US-1,004,0826 Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens
The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
US-1,004,0825 Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
This invention relates to soluble forms of F glycoprotein from Hendra and Nipah virus and to compositions comprising soluble forms of F glycoprotein from Hendra...
US-1,004,0824 Flavivirus vaccine
Replicon virus-like particles can be used as flavivirus vaccines.
US-1,004,0823 In vivo methods of monitoring biodistribution
Functional-lipid constructs of the structure F-S-L are disclosed, wherein F comprises a tyrosine or histidine residue, S is a spacer covalently linking F to L...
US-1,004,0822 Neuroprotective composition and method of use
A therapeutic composition for treating brain injury comprising a polyarginine peptide of from 5 to 9 arginines (SEQ ID NO: 1), and further comprising 1 or more...
US-1,004,0821 Compositions containing HC-HA/PTX3 complexes and methods of use thereof
Provided herein are methods for the production of native and reconstituted hyaluronan (HA) complexes containing pentraxin-3 (PTX3) and heavy chain 1 (HC1) of...
US-1,004,0820 Method for the purification of protein complexes
The present invention provides an improved method for the purification of a mixture of complexes comprising a stress protein complexed to a peptide or peptide...
US-1,004,0819 Chemically modifying peptides
A method for chemically modifying a peptide, derivative or analogue thereof is described. The method comprises contacting a peptide, derivative or analogue...
US-1,004,0818 Selective photoactivation of amino acids for single step peptide coupling
Disclosed herein are formulations, substrates, and arrays for amino acid and peptide synthesis on microarrays. In certain embodiments, methods for manufacturing...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.